NEOMAB BIO Trademark

Trademark Overview


On Tuesday, February 6, 2024, a trademark application was filed for NEOMAB BIO with the United States Patent and Trademark Office. The USPTO has given the NEOMAB BIO trademark a serial number of 98394125. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 3, 2025. This trademark is owned by GemPharmatech Co., Ltd.. The NEOMAB BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biological research; Chemical research; Conducting of feasibility studies in the field of new technologies; Culturing of cells for others for scientific research purposes; Medical research; Research and development of new products for others; Research in the field of gene editing technology; Scientific laboratory services; Scientific research; Scientific research in the field of genetics
neomab bio

General Information


Serial Number98394125
Word MarkNEOMAB BIO
Filing DateTuesday, February 6, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, June 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 3, 2025

Trademark Statements


Pseudo MarkNEO MONOCLONAL ANTIBODY
NOT AVAILABLE"BIO"
Translation of Words in MarkThe wording "NEOMAB BIO" has no meaning in a foreign language.
Goods and ServicesBiological research; Chemical research; Conducting of feasibility studies in the field of new technologies; Culturing of cells for others for scientific research purposes; Medical research; Research and development of new products for others; Research in the field of gene editing technology; Scientific laboratory services; Scientific research; Scientific research in the field of genetics

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 6, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGemPharmatech Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNanjing, Jiangsu 210000
CN

Party NameGemPharmatech Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNanjing, Jiangsu 210000
CN

Trademark Events


Event DateEvent Description
Tuesday, June 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 29, 2024NON-FINAL ACTION WRITTEN
Thursday, August 29, 2024ASSIGNED TO EXAMINER
Thursday, August 29, 2024NON-FINAL ACTION E-MAILED
Thursday, August 29, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 6, 2024NEW APPLICATION ENTERED
Friday, November 1, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 1, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 1, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 4, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, May 1, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 1, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 1, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 1, 2025ASSIGNED TO LIE
Tuesday, June 3, 2025PUBLISHED FOR OPPOSITION
Tuesday, June 3, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 28, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 4, 2024LETTER OF SUSPENSION E-MAILED
Monday, November 4, 2024SUSPENSION LETTER WRITTEN
Thursday, April 17, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED